Back to search

Article

FSTL3 is a biomarker of poor prognosis and is associated with immunotherapy resistance in ovarian cancer

2024-12-12

Abstract excerpt

High-grade serous ovarian carcinoma (HGSOC), is associated with high mortality rates due to late-stage diagnosis and limited treatment options. We investigated the role of FSTL3 in ovarian cancer progression both as a prognostic biomarker and as a potential therapeutic target. We measured levels of follistatin (FST) and follistatin-like 3 (FSTL3) in 96 ovarian cancer patient ascites samples and found that FSTL3 ov...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
899ba063-f84a-5514-9a15-850819d9e1a8
DOI
10.1101/2024.12.10.627747
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
FSTL3 is a biomarker of poor prognosis and is associated with immunotherapy resistance in ovarian cancerDOI 10.1101/2024.12.10.627747
Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal CancerSemantic proximity
Follistatin-like 1 (FSTL1) is a prognostic biomarker and correlated with immune cell infiltration in gastric cancerSemantic proximity
CSF3 contributes to the invasive and metastatic phenotypes and associates with poor prognosis in patients with colorectal cancer via NF-κB signaling pathwaySemantic proximity
LGR4 Maintains HGSOC Cell Epithelial Phenotype and Stem-Like TraitsSemantic proximity
Mesothelin expression correlates with elevated inhibitory immune activity in patients with colorectal cancerSemantic proximity
The prognostic and immune significance of SLAMF9 in pan-cancer and validation of its role in colorectal cancerSemantic proximity
New immune phenotypes for treatment response in high-grade serous ovarian carcinoma patients.Semantic proximity
GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma.Semantic proximity
Ovarian Tumor FAK Inhibition Releases Omega-3 Fatty Acids Stimulating GATA6 Peritoneal Macrophage CXCL13 Production Enhancing ImmunotherapySemantic proximity
APOBEC3A drives metastasis of high-grade serous ovarian cancer by altering epithelial-to-mesenchymal transitionSemantic proximity
Characterizing the genomic landscape through the lens of FOLR1 status in low and high grade serous ovarian carcinoma.Semantic proximity
VGLL3 expression is associated with macrophage infiltration and predicts poor prognosis in epithelial ovarian cancerSemantic proximity
Select a neighboring publication to make it the new centre.